1. 1. Srinath RK, Shah B, Varghese C and Ramadoss A. Responding to the threat of chronic diseases in India. Lancet. 2005; 366:1744–1749.
   2.  Cosention F, Sill JC and Katusic ZS. Role of superoxide anions in the mediation of endothelium dependent contractions. Hypertension.1994; 23(2): 229-235
   3.  Oparil S, Zaman MA and Calhoun DA. Pathogenesis of hypertension. Annals of Internal Medicine. 2003; 139(9):761-76.
   4. Razzo A M, Berselli P, Zava S, Montorfano G, Negroni M and Corsetto P et al. Endogenous Antioxidants and Radical Scavengers. Advance in Experimental Medicine and Biology. 2010; 698:52- 63.
   5.  Miller NJ and Rice-Evans A. Spectrophotometric determination of antioxidant activity. Communications in free radical research. 1996; 2 (3): 161-171.
   6. Lanone S, Bloc S, Foresti R, Almolki A, Taille C and Callebert J et al. Bilirubin decreases NOS2 expression via inhibition of NAD(P)H oxidase: implications for protection against endotoxic shocks in rats. FASEB Journal. 2005;19(13): 1890-1892.
   7.  Kayce B, Twiggs J and Bernie R. Hypertension: The Silent killer: Updated JNC-8 Guideline Recommendations. Continuing Education. 2015; 1-7.
   8. Benzie FFI and Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: The FRAP assay. Analytical biochemistry.1996; 239(1):70-76.
   9. Doumas BT, Watson WA and Biggs HG. Albumin standards and the measurement of serum albumin with bromcresol green. Clinical chemistry. 1971; 31(1): 87-96
   10. Hasebe Y, Nawa K, Ujita S and Uchiyama S. Highly sensitive flow detection of uric acid based on an intermediate regeneration of uricase. Analyst. 1998; 123:1775-1780.
   11. Henry RJ. Clinical Chemistry, Principal and Technics, Harper and Row Publishers, Hagerstown, Maryland. 1974; 1058.